Phase II study of gemcitabine and cisplatin in women with taxane-failed metastatic breast cancer (MBC)

被引：0
|
作者：
Wang, T. [1 ]
Jiang, Z. [1 ]
Song, S. [1 ]
Shen, G. [1 ]
Zhang, S. [1 ]
Wu, S. [1 ]
Zeng, M. [1 ]
机构：
[1] 307 Hosp Affiliated, Mil Med Acad, Ctr Canc, Beijing, Peoples R China
来源：
EJC SUPPLEMENTS | 2005年 / 3卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：127 / 127
页数：1
相关论文
共 50 条
  • [1] Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer
    Seo, Jae Hong
    Oh, Sang Cheul
    Choi, Cheul Won
    Kim, Byung Soo
    Shin, Sang Won
    Kim, Yeul Hong
    Kim, Jun Suk
    Kim, Ae-Ree
    Lee, Jae-Bok
    Koo, Bum Hwan
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2007, 59 (02) : 269 - 274
  • [2] Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer
    Jae Hong Seo
    Sang Cheul Oh
    Cheul Won Choi
    Byung Soo Kim
    Sang Won Shin
    Yeul Hong Kim
    Jun Suk Kim
    Ae-Ree Kim
    Jae-Bok Lee
    Bum Hwan Koo
    Cancer Chemotherapy and Pharmacology, 2007, 59 : 269 - 274
  • [3] Phase II study of a gemcitabine and cisplatin combination regimen in taxane resistant metastatic breast cancer
    Seo, Jae Hong
    Choi, In Keun
    Kim, Seok Jin
    Oh, Sang Cheul
    Shin, Sang Won
    Kim, Yeul Hong
    Lee, Jae-Bok
    Kim, Ae-Ree
    Koo, Bum Hwan
    Kim, Jun Suk
    ANNALS OF ONCOLOGY, 2006, 17 : 72 - 72
  • [4] Randomized phase II trial of three gemcitabine (GEM)-taxane combinations in metastatic breast cancer (MBC).
    Khoo, KS
    Zaidi, M
    Srimuninnimit, V
    Jiang, ZF
    Prem Kumar, P
    Bustam, A
    Villalon, AH
    Lehnert, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 54S - 54S
  • [5] Phase II study of gemcitabine plus cisplatin in metastatic breast cancer
    Fuentes, Homero
    Calderillo, German
    Alexander, Francisco
    Ramirez, Marcelino
    Avila, Enrique
    Perez, Leonel
    Aguirre, Guillermo
    Onate-Ocana, Luis F.
    Gallardo, Dolores
    Otero, Jorge
    ANTI-CANCER DRUGS, 2006, 17 (05) : 565 - 570
  • [6] Phase II study of weekly gemcitabine in patients with metastatic breast cancer (mbc) relapsing or failing on both an anthracycline (A) and a taxane (T).
    Smorenburg, C
    Bontenbal, M
    Seynaeve, C
    van Zuylen, L
    de Heus, G
    Verweij, J
    de Wit, R
    ANNALS OF ONCOLOGY, 2000, 11 : 31 - 31
  • [7] A phase II pilot study of vinorelbine and cisplatin in patients with metastatic breast cancer (MBC)
    Abraham, J
    McAdam, K
    Wilson, CB
    Earl, HM
    BRITISH JOURNAL OF CANCER, 2001, 85 : 51 - 51
  • [8] Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study
    Schmid, P
    Heilmann, V
    Schulz, CO
    Dieing, A
    Lehenbauer-Dehm, S
    Jehn, C
    Sezer, O
    Possinger, K
    Flath, B
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2005, 131 (09) : 568 - 574
  • [9] Gemcitabine as prolonged infusion and vinorelbine in anthracycline and/or taxane pretreated metastatic breast cancer: a phase II study
    Peter Schmid
    Volker Heilmann
    Carsten-Oliver Schulz
    Annette Dieing
    Silvia Lehenbauer-Dehm
    Christian Jehn
    Orhan Sezer
    Kurt Possinger
    Bernd Flath
    Journal of Cancer Research and Clinical Oncology, 2005, 131 : 568 - 574
  • [10] Gemcitabine (G) and cisplatin (C) as first-line treatment of metastatic breast cancer (MBC): Results of phase II trial
    Karthaus, Meinolf
    Poddubnaya, Irina
    Churilova, L.
    Khazanov, R.
    Veremeychuk, T.
    Rumyantzeva, E.
    Garin, M.
    Brichkova, O.
    Heinrich, Bernhard
    Heinemann, Volker
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345